Vitamin d in pregnancy fails to prevent asthma in kids
NCT ID NCT00920621
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested whether giving pregnant women daily vitamin D supplements (4000 IU) could prevent asthma or recurrent wheezing in their children during the first three years of life. The trial enrolled 876 pregnant women with a personal or family history of asthma or allergies. Results showed no significant reduction in asthma or wheeze compared to a placebo.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- vitamin D3 (cholecalciferol)
- What this could lead to
- If it worked, this could point toward a simple way to reduce childhood asthma risk by giving vitamin D to pregnant women.
- What could go wrong
- The trial was completed but did not show a clear benefit. The results are uncertain and may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
876 people
The number who actually took part.
- Start date
-
Sep 2009
- Finished
-
Aug 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 39 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Personal history of asthma, eczema, allergic rhinitis or a history of asthma, eczema, allergic rhinitis in the biological father of the child * Gestational age between 10 and 18 weeks at the time of randomization * Maternal age between 18 and 39 years * Not a current smoker * English or Spanish speaking * Intent to participate for the full 4 years (through Pregnancy and then until the 3rd birthday of the child) Exclusion Criteria: * Not meeting inclusion criteria * Gestational age greater than 18 weeks * Presence of chronic medical conditions * Taking vitamin D supplements containing more than 2000 IU/day of vitamin D3 * Multiple gestation pregnancy (twins, triplets) * Pregnancy achieved by assisted reproduction techniques (e.g., IUI, IVF)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Asthma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
George O'Connor, MD
Boston, Massachusetts, United States
-
Leonard Bacharier, MD
St Louis, Missouri, United States
-
Robert Zeiger, MD
San Diego, California, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple breath test cut asthma Flare-Ups?
- Breathing tests face off: can extra lung measurements improve asthma diagnosis?
- The carbon label on your inhaler: can it sway a Doctor's choice?
- Six biologics put to the test in Real-World asthma and COPD care
- Can a digital program help teens with chronic illnesses move to adult care?
- Why do some kids catch every cold? a 1,200-Child study hunts for immune clues